|
|
Issue
|
Alert me when new journal issues are available via  or via  |
|
|
| Neurotherapeutics |
| Volume 4, Issue 4, Pages 569-738 (October 2007) |
|
Search Within This Issue
|
| Neuroimmunology in Neurotherapeutics
|
| Edited by Richard Ransohoff, Scott Zamvil |
|
|
|
|
|
|
 =free full text
|
|
|
|
Editorial
|
|
Neuroimmunotherapeutics Comes of Age
Richard M. Ransohoff, Scott S. Zamvil
pages 569-570
Full Text |
Full-Text PDF (26 KB)
|
|
|
Review Articles
|
|
A Rose by Any Other Name? The Potential Consequences of Microglial Heterogeneity During CNS Health and Disease
Monica J. Carson, Tina V. Bilousova, Shweta S. Puntambekar, Benoit Melchior, Jonathan M. Doose, Iryna M. Ethell
pages 571-579
Abstract |
Full Text |
Full-Text PDF (612 KB)
|
|
Targeting MMPs in Acute and Chronic Neurological Conditions
V. Wee Yong, Smriti M. Agrawal, David P. Stirling
pages 580-589
Abstract |
Full Text |
Full-Text PDF (158 KB)
|
|
Chemokines and Chemokine Receptors in Neurological Disease: Raise, Retain, or Reduce?
Carine Savarin-Vuaillat, Richard M. Ransohoff
pages 590-601
Abstract |
Full Text |
Full-Text PDF (2488 KB)
|
|
MRI in Multiple Sclerosis: What’s Inside the Toolbox?
Mohit Neema, James Stankiewicz, Ashish Arora, Zachary D. Guss, Rohit Bakshi
pages 602-617
Abstract |
Full Text |
Full-Text PDF (1674 KB)
|
|
Corticosteroids for Multiple Sclerosis: I. Application for Treating Exacerbations
Elliot M. Frohman, Anjali Shah, Eric Eggenberger, Luanne Metz, Robert Zivadinov, Olaf Stüve
pages 618-626
Abstract |
Full Text |
Full-Text PDF (112 KB)
|
|
Corticosteroids for Multiple Sclerosis: II. Application for Disease-Modifying Effects
Anjali Shah, Eric Eggenberger, Robert Zivadinov, Olaf Stüve, Elliot M. Frohman
pages 627-632
Abstract |
Full Text |
Full-Text PDF (83 KB)
|
|
Interferon-β Treatment for Multiple Sclerosis
Robert A. Bermel, Richard A. Rudick
pages 633-646
Abstract |
Full Text |
Full-Text PDF (323 KB)
|
|
Mechanism of Action of Glatiramer Acetate in Treatment of Multiple Sclerosis
Martin S. Weber, Reinhard Hohlfeld, Scott S. Zamvil
pages 647-653
Abstract |
Full Text |
Full-Text PDF (162 KB)
|
|
Immunosuppressive Agents in Multiple Sclerosis
Oliver Neuhaus, Bernd C. Kieseier, Hans-Peter Hartung
pages 654-660
Abstract |
Full Text |
Full-Text PDF (105 KB)
|
|
Antigen-Specific Therapy of Multiple Sclerosis: The Long-Sought Magic Bullet
Lawrence Steinman
pages 661-665
Abstract |
Full Text |
Full-Text PDF (74 KB)
|
|
Modulating Co-Stimulation
Vissia Viglietta, Samia J. Khoury
pages 666-675
Abstract |
Full Text |
Full-Text PDF (166 KB)
|
|
Emerging Therapies for Multiple Sclerosis
Paolo A. Muraro, Bibiana Bielekova
pages 676-692
Abstract |
Full Text |
Full-Text PDF (308 KB)
|
|
Statins—Treatment Option for Central Nervous System Autoimmune Disease?
Martin S. Weber, Lawrence Steinman, Scott S. Zamvil
pages 693-700
Abstract |
Full Text |
Full-Text PDF (161 KB)
|
|
Prospects for Neural Stem Cell-Based Therapies for Neurological Diseases
Jaime Imitola
pages 701-714
Abstract |
Full Text |
Full-Text PDF (864 KB)
|
|
Immunology of Neurological Gene Therapy: How T Cells Modulate Viral Vector-Mediated Therapeutic Transgene Expression Through Immunological Synapses
Pedro R. Lowenstein, Kurt Kroeger, Maria G. Castro
pages 715-724
Abstract |
Full Text |
Full-Text PDF (1263 KB)
|
|
|
Abstracts
|
|
Poster Abstract #1: Passive and Active Functional Tasks Are the Main Reasons for Treatment of Upper Limb Spasticity in Post-Stroke Patients Among Neurologists, Physiatrists, and Primary Care Physicians
Amanda M. VanDenburgh, Susan Abu-Shakra, Mitchell F. Brin, Frederick Beddingfield
page 725
Full Text |
Full-Text PDF (39 KB)
|
|
Poster Abstract #2: A Cluster Analysis of Treatment Response in Acute Bipolar Mania
Ilya Lipkovich, John P. Houston, Jonna Ahl
page 725
Full Text |
Full-Text PDF (39 KB)
|
|
Poster Abstract #3: Cognitive Status of Patients With Schizophrenia as Modulator or Mediator of Functional Outcome
Ilya Lipkovich, Sara Kollack-Walker, Bruce Kinon, Virginia Stauffer, Haya Ascher-Svanum, Richard Keefe
pages 725-726
Full Text |
Full-Text PDF (46 KB)
|
|
Poster Abstract #4: Metabotropic Glutamate Receptor 5 Modulates Microglial Activity and Provides Neuroprotection
Kimberly R. Byrnes, Bogdan Stoica, Alan I. Faden
page 726
Full Text |
Full-Text PDF (38 KB)
|
|
Poster Abstract #5: NAIP-based Neuroprotection Drug Screening
Kazunori Tanaka, Yoshinori Okada, Harumi Sakai, Asako Otomo, Shinji Hadano, Hitoshi Osuga, Joh-E. Ikeda
page 726
Full Text |
Full-Text PDF (38 KB)
|
|
Poster Abstract #6: Age-Related Motor Impairment in Mice Lacking Vg1037, an Orphan GPCR Localized to Brain Motor Systems
Richard Torres, J. Vercollone, K.D. Anderson, S.D. Croll, G.D. Yancopoulos, S.J. Wiegand, A.J. Murphy
pages 726-727
Full Text |
Full-Text PDF (48 KB)
|
|
Poster Abstract #7: Anticonvulsant Effects of a Synthetic Progestin, Norethindrone, But Not Its A-Ring Reduced Metabolite in Mice
Rafal M. Kaminski, Scott P. Runyon, Herbert Marini, Michael A. Rogawski
page 727
Full Text |
Full-Text PDF (41 KB)
|
|
Poster Abstract #8: PARP Inhibitors Attenuate Secondary Neuronal Cell Death and Improve Neurological Dysfunction After Traumatic Brain Injury
Bogdan A. Stoica, Kimberly R. Byrnes, Alan I. Faden
page 727
Full Text |
Full-Text PDF (41 KB)
|
|
Poster Abstract #9: Implementing Data Standards: Challenges from the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Common Data Elements Project
Selma C. Kunitz
pages 727-728
Full Text |
Full-Text PDF (48 KB)
|
|
Poster Abstract #10: Preliminary Experience With Functional MRI (fMRI) Detects Altered Neural Networks Subserving Executive Function and Attention in Subjects With Partial Ornithine Transcarbamylase Deficiency (OTC)
Andrea Gropman, Ayichew Hailu, Rebecca Seltzer, Stanley Fricke, John van Meter
page 728
Full Text |
Full-Text PDF (38 KB)
|
|
Poster Abstract #11: A Research Network for the Experimental Therapeutics of Rare Neurologic Disorders
Barbara E. Herr, Rachel Richesson, Robert C. Griggs, CINCH Consortium
page 728
Full Text |
Full-Text PDF (38 KB)
|
|
Poster Abstract #12: Continuous Subcutaneous Apomorphine as an Aid in Regaining Consciousness After a Severe Traumatic Brain Injury
Esteban Fridman, Ben-Zion Krimchansky, Tatiana Galperin, Elkan Gamzu, Mariana Bonetto
pages 728-729
Full Text |
Full-Text PDF (46 KB)
|
|
Poster Abstract #13: Possible Role of Primidone in the Treatment of Restless Leg Syndrome (RLS)
Krishna Mettu, Mandeep Garewal, Manjamali Sivaraman, Pradeep Sahota
page 729
Full Text |
Full-Text PDF (39 KB)
|
|
Poster Abstract #14: Recruiting Older Diverse Populations into Studies of Parkinson’s Disease: A Mixed Methods Approach to Development of an Intervention
Barbara C. Tilley, Arch Mainous, Dan Smith, Jordan Elm
pages 729-730
Full Text |
Full-Text PDF (46 KB)
|
|
Poster Abstract #15: Preliminary Experience With MRS at 3T in Urea Cycle Disorders Detects Altered Metabolism in Partial Ornithine Transcarbamylase Deficiency
Andrea Gropman, Ayichew Hailu, Rebecca Seltzer, Stanley Fricke, John van Meter, Mark Batshaw, Mendel Tuchman
page 730
Full Text |
Full-Text PDF (38 KB)
|
|
Poster Abstract #16: Building Patient Trust in Clinical Research: The Parkinson’s Disease Experience
Robin Elliott, Veronica Todaro
page 730
Full Text |
Full-Text PDF (38 KB)
|
|
Poster Abstract #17: Double-Blind Randomized Treatment of Poststroke Depression With Nefiracetam
Robert G. Robinson, Ricardo E. Jorge, Sergio E. Starkstein
page 730
Full Text |
Full-Text PDF (38 KB)
|
|
Poster Abstract #18: National Institutes of Health Rapid Access to Interventional Development (NIH-RAID) Pilot Program
D. Badman, T. Jackson, T. Miller
page 731
Full Text |
Full-Text PDF (31 KB)
|
|
|
Indices
|
|
Author Index
pages 732-733
Full-Text PDF (24 KB)
|
|
Subject Index
pages 734-737
Full-Text PDF (38 KB)
|
|
|
Frontmatter
|
|
Editorial Board
page A1
Full-Text PDF (21 KB)
|
|
Contents
pages A2-A3
Full-Text PDF (36 KB)
|
|
|
|
|
